Wynzora (calcipotriene/betamethasone dipropionate) / MC2 Therap, Almirall 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wynzora (calcipotriene/betamethasone dipropionate) / MC2 Therap, Almirall
psowyn, NCT06180473: Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream

Not yet recruiting
N/A
30
NA
questionnaire
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Psoriasis
03/24
06/24
PRO-SCALP, NCT05811234: A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

Active, not recruiting
N/A
291
Europe
CAL/BDP PAD Cream, Wynzora®
Almirall, S.A.
Plaque Psoriasis
08/24
08/24

Download Options